Retroviral particles expressing Sirt1 embedded within PPCN
AssigneeNortwestern University
InventorsGuillermo A. Ameer, Michele Jen
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided for improved wound healing. In particular, provided herein are compositions and methods for the direct delivery of Sirtuin-1 (Sirt1) or vectors encoding Sirt1 to the wounds (e.g., of diabetic patients). In some embodiments, provided herein are therapeutic devices comprising: (a) a vector encoding Sirtuin-1 (Sirt 1); and (b) a hydrogel carrier. In some embodiments, the vector comprises a viral vector comprising a polynucleotide sequence encoding Sirt 1. In some embodiments, the vector comprises a non-viral vector comprising a polynucleotide sequence encoding Sirt1.
Claims4
A composition comprising a lentiviral particle comprising (a) a nucleic acid sequence with at least 70% sequence identity with SEQ ID NO:
- 1 and encoding a Sirt1 polypeptide that exhibits deacetylase activity, and (b) a poly(polyethyleneglycol co-citric acid-co-N isopropylacrylamide) (PPCN) carrier material.
Dependencies are inferred from the claim text.